BioForce Nanosciences Holdings, Inc.

BFNH · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$490-$472-$486-$502
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$429$425$417$424
Other Non-Cash$0$0$0$0
Operating Cash Flow-$61-$47-$68-$78
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$8$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$53$47$58$49
Financing Cash Flow$61$47$58$49
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$0-$10-$29
Supplemental Information
Beg. Cash$1$1$11$40
End Cash$1$1$1$11
Free Cash Flow-$61-$47-$68-$78
BioForce Nanosciences Holdings, Inc. (BFNH) Financial Statements & Key Stats | AlphaPilot